Romanian Inventory of Depression and Anxiety Symptoms (IDAS-II)

Overview

Journal Front Psychol

Date 2023 Jul 24

PMID 37484097

Authors

Ligiana Mihaela Petre

Delia Alexandra Gheorghe

David Watson

Laurentiu Mitrofan

Affiliations

Soon will be listed here.

Abstract

Background: The Inventory of Depression and Anxiety Symptoms (IDAS-II) is a self-report measure comprising 99 items divided into 18 non-overlapping scales that allows for a dimensional assessment of depression, anxiety, and bipolar symptoms. The IDAS-II is currently available in English, Turkish, Spanish, German, and Swedish. This study's major goal was to adapt and validate the IDAS-II to the Romanian population.

Method: Participants from a community sample ( = 1,072) completed the IDAS-II (Romanian version) and additional measures assessing depression and anxiety disorders.

Results: Item-level factor analyses validated the unidimensionality of the scales, and internal consistency results indicated that most symptom scales had satisfactory alpha coefficient values. Based on previous structural analyses, a confirmatory factor analysis (CFA) on the IDAS-II scales confirmed a three-component model of "Distress," "Obsessions/Fear," and "Positive Mood." Convergent and discriminant validity were established by correlational analyses with other symptom measures.

Limitations: This study was conducted using a sample from the general population and several of the employed measures have limitations. Specifically, the current study was unable to employ Romanian versions of the gold-standard instruments that assess well-being, obsessive-compulsive disorder, and claustrophobia.

Conclusion: The IDAS-II (Romanian version) is the first clinical measure to assess internalizing dimensions of the Hierarchical Taxonomy of Psychopathology (HiTOP) model that is available for the Romanian population.

Citing Articles

Discriminative capacity of the Spanish version of the Inventory of Depression and Anxiety Symptoms-II (IDAS-II) for detecting DMS-5 specific disorders and poor quality of life in a clinical sample.

Sanchez-Garcia M, Diaz-Batanero C, de la Rosa-Caceres A Health Qual Life Outcomes. 2024; 22(1):56.

PMID: 39020397 PMC: 11256423. DOI: 10.1186/s12955-024-02270-x.

References

Kotov R, Krueger R, Watson D, Achenbach T, Althoff R, Bagby R . The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies. J Abnorm Psychol. 2017; 126(4):454-477. DOI: 10.1037/abn0000258. View

Machado P, Machado B, Goncalves S, Hoek H . The prevalence of eating disorders not otherwise specified. Int J Eat Disord. 2006; 40(3):212-7. DOI: 10.1002/eat.20358. View

Baxter A, Vos T, Scott K, Ferrari A, Whiteford H . The global burden of anxiety disorders in 2010. Psychol Med. 2014; 44(11):2363-74. DOI: 10.1017/S0033291713003243. View

Ferrari A, Charlson F, Norman R, Patten S, Freedman G, Murray C . Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013; 10(11):e1001547. PMC: 3818162. DOI: 10.1371/journal.pmed.1001547. View

Kashdan T, Morina N, Priebe S . Post-traumatic stress disorder, social anxiety disorder, and depression in survivors of the Kosovo War: experiential avoidance as a contributor to distress and quality of life. J Anxiety Disord. 2008; 23(2):185-96. PMC: 2667796. DOI: 10.1016/j.janxdis.2008.06.006. View

De la Rosa-Caceres A, Lozano O, Sanchez-Garcia M, Fernandez-Calderon F, Rossi G, Diaz-Batanero C . Assessing Internalizing Symptoms and Their Relation with Levels of Impairment: Evidence-Based Cutoffs for Interpreting Inventory of Depression and Anxiety Symptoms (IDAS-II) Scores. J Psychopathol Behav Assess. 2023; 45(1):170-180. PMC: 9830132. DOI: 10.1007/s10862-022-10008-6. View

Narrow W, Clarke D, Kuramoto S, Kraemer H, Kupfer D, Greiner L . DSM-5 field trials in the United States and Canada, Part III: development and reliability testing of a cross-cutting symptom assessment for DSM-5. Am J Psychiatry. 2012; 170(1):71-82. DOI: 10.1176/appi.ajp.2012.12071000. View

Kotov R, Jonas K, Carpenter W, Dretsch M, Eaton N, Forbes M . Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum. World Psychiatry. 2020; 19(2):151-172. PMC: 7214958. DOI: 10.1002/wps.20730. View

Satorra A, Bentler P . Ensuring Positiveness of the Scaled Difference Chi-square Test Statistic. Psychometrika. 2010; 75(2):243-248. PMC: 2905175. DOI: 10.1007/s11336-009-9135-y. View

10.

Fried E, Nesse R . The impact of individual depressive symptoms on impairment of psychosocial functioning. PLoS One. 2014; 9(2):e90311. PMC: 3938686. DOI: 10.1371/journal.pone.0090311. View

11.

Watson D, OHara M, Naragon-Gainey K, Koffel E, Chmielewski M, Kotov R . Development and validation of new anxiety and bipolar symptom scales for an expanded version of the IDAS (the IDAS-II). Assessment. 2012; 19(4):399-420. DOI: 10.1177/1073191112449857. View

12.

Kotov R, Krueger R, Watson D, Cicero D, Conway C, DeYoung C . The Hierarchical Taxonomy of Psychopathology (HiTOP): A Quantitative Nosology Based on Consensus of Evidence. Annu Rev Clin Psychol. 2021; 17:83-108. DOI: 10.1146/annurev-clinpsy-081219-093304. View

13.

Markon K, Chmielewski M, Miller C . The reliability and validity of discrete and continuous measures of psychopathology: a quantitative review. Psychol Bull. 2011; 137(5):856-79. DOI: 10.1037/a0023678. View

14.

De la Rosa-Caceres A, Stasik-OBrien S, Rojas A, Sanchez-Garcia M, Lozano O, Diaz-Batanero C . Spanish Adaptation of the Inventory of Depression and Anxiety Symptoms (IDAS-II) and a study of its psychometric properties. J Affect Disord. 2020; 271:81-90. DOI: 10.1016/j.jad.2020.03.187. View

15.

Irak M, Albayrak E . Psychometric Properties of the Expanded Version of the Inventory of Depression and Anxiety Symptoms in a Turkish Population. Psychol Rep. 2018; 123(2):517-545. DOI: 10.1177/0033294118813844. View

16.

Donohue J, Pincus H . Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment. Pharmacoeconomics. 2006; 25(1):7-24. DOI: 10.2165/00019053-200725010-00003. View

17.

Krueger R, Kotov R, Watson D, Forbes M, Eaton N, Ruggero C . Progress in achieving quantitative classification of psychopathology. World Psychiatry. 2018; 17(3):282-293. PMC: 6172695. DOI: 10.1002/wps.20566. View

18.

Clark L, WATSON D . Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991; 100(3):316-36. DOI: 10.1037//0021-843x.100.3.316. View

19.

Beck A, Epstein N, Brown G, Steer R . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988; 56(6):893-7. DOI: 10.1037//0022-006x.56.6.893. View

20.

Sanchez-Garcia M, de la Rosa-Caceres A, Stasik-OBrien S, Mancheno-Barba J, Lozano O, Diaz-Batanero C . Norms According to Age and Gender for the Spanish Version of the Inventory of Depression and Anxiety Symptoms (IDAS-II). Front Psychol. 2021; 12:748025. PMC: 8531198. DOI: 10.3389/fpsyg.2021.748025. View